Key Takeaways For the Management of Plaque Psoriasis

EP: 1.Recent Approvals in the Management of Plaque Psoriasis

EP: 2.Clinical Experiences With Bimekizumab

EP: 3.Efficacy and Safety of Bimekizumab in Plaque Psoriasis

EP: 4.Efficacy and Safety of Spesolimab and Deucravacitinib

EP: 5.Nonsteroidal Topical Treatments for Plaque Psoriasis

EP: 6.Pediatric Plaque Psoriasis Treatment and Considerations for Patients With Skin of Color

EP: 7.Looking Ahead for the Management of Plaque Psoriasis

Now Viewing

EP: 8.Key Takeaways For the Management of Plaque Psoriasis

EP: 9.Reviewing a Year of Plaque Psoriasis Progress: Therapies, Data, and Education

This is a video synopsis of a discussion involving Mark Lebwohl, MD, Dean for Clinical Therapeutics and Chairman Emeritus of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in Manhattan, New York, and Saakshi Khattri, MD, a board-certified dermatologist, rheumatologist, and internist at the same institution.

Dr. Khattri and Dr. Lebwohl discuss advancements in psoriasis (PsO) and psoriatic arthritis (PsA) treatment paradigms. Dr. Khattri emphasizes the importance of early PsA diagnosis for optimal therapeutic outcomes. She recounts a case where early identification of PsA symptoms allowed for timely intervention with an anti-tumor necrosis factor (TNF) therapy, resulting in significant symptom improvement and prevention of disease progression.

Dr. Lebwohl underscores the value of incorporating joint pain assessment into routine patient evaluations, highlighting its impact on treatment selection. He applauds the proactive approach taken by medical assistants at their institution in screening for joint pain, emphasizing its pivotal role in guiding therapeutic decisions.

Both panelists stress the transformative impact of early intervention in PsA management, leading to improved patient outcomes and reduced disease burden. They conclude by encouraging healthcare providers to prioritize early detection and intervention strategies in PsO and PsA care.

In closing, Dr. Lebwohl expresses gratitude to Dr. Khattri for her insights and contributions to the discussion, highlighting the importance of ongoing education and collaboration in advancing dermatologic care.

Thank you all for watching this Dermatology Times® DermView discussion. If you enjoyed the content, please subscribe to our e-newsletters to receive upcoming video programs and other great content right in your inbox.

Video synopsis is AI-generated and reviewed by Dermatology Times® editorial staff.